Potential Application of Nanoparticles as Antipathogens - Advanced Materials for Agriculture, Food and Environmental Safety - page 365

103. R.P.F. Schins, A. McAlinden, W. MacNee, L.A. Jimenez, J.A. Ross, K. Guy, et
al ., “Persistent depletion of I kappa B alpha and interleukin-8 expression in
human pulmonary epithelial cells exposed to quartz particles”, Toxicol. Appl.
Pharmacol. , Vol. 167, pp. 107-117, 2000.
104. A. Peters, C.A. Pope III, “Cardiopulmonary mortality and air pollution”,
Lancet , Vol. 360, pp. 1184-1185, 2002.
105. A. Radomski, P. Jurasz, D. Alonso-Escolano, M. Drews, M. Morandi, T.
Malinski, et al ., “Nanoparticle-induced platelet aggregation and vascular
thrombosis”, Br. J. Pharmacol. ,Vol. 146, pp. 882-893, 2005.
106. A. Radomski, P. Jurasz, D. Alonso-Escolano, M. Drews, M. Morandi, T.
Malinski, et al ., “Nanoparticle-induced platelet aggregation and vascular
thrombosis”, Br. J. Pharmacol. ,Vol. 146, pp. 882-893, 2005.
107. D. Panatarotto, C.D. Prtidos, J. Hoebeke, F. Brown, E. Kramer, J.P. Briand,
S. Muller, M. Prato, A. Bianco, “Immunization with peptide-functionalized
carbon nanotubes enhances virus-specii c neutralizing antibody responses”,
Chemistry & Biology , Vol. 10, pp. 961-966, 2003.
108. C.A. Pope, “Particulate air pollution, C-reactive protein, and cardiac risk”,
Eur. Heart J. ,Vol. 22, pp 1149-1150, 2001.
109. P. Jani, G.W. Halbert, J. Langridge, A.T. Florence, “Nanoparticle uptake by
the rat gastrointestinal mucosa: Quantitation and particle size dependency”,
J. Pharm. Pharmacol. ,Vol. 42, pp. 821-826, 1990.
110. A.A. Shvedova, V. Castranova, E.R. Kisin, D. Schwegler-Berry, A.R. Murray,
V.Z. Gandelsman, et al ., “Exposure to carbon nanotube material: Assessment
of nanotube cytotoxicity using human keratinocyte cells”, J. Toxicol. Environ.
Health: A ,Vol. 66, pp. 1909-1926, 2003.